Kazuma Nakashima

16PUBLICATIONS
5CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)BiomaterialsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 14, 2026
Improving Pharmacokinetics of PSMA/GRPR-Targeting Radiolabeled Heterodimer through Enhanced Albumin Binding.

|Jun 23, 2026
Systematic Investigation of Fatty Acids with Different Carbon-Chain Length as Albumin Binder to Improve Tumor Accumulation of Radioligands.

|Jun 18, 2026
Head-to-Head Comparison of Monomeric, Homodimeric, and Heterodimeric Fibroblast Activation Protein-Targeting Radioligands Based on Small Molecule Inhibitor and Cyclic Peptide.

|Jun 12, 2026
Development of Novel Cholecystokinin 2 Receptor-Targeted Radioligand Containing Albumin Binder for Efficient 111In/177Lu Theranostics.

|Mar 24, 2026
Influence of the Binding Valency of Anti-HER2 Biparatopic Antibodies on Biodistribution in an SK-OV-3 Tumor Xenograft Model.

Hiroki Akiba, Kazuma Nakashima, Takayoshi Ichinose

|Feb 19, 2026
Effect of Structural Alteration in Albumin Binder Moiety on Tumor Accumulation of Somatostatin Receptor 2‑Targeted Radioligands.

Takuma Yamane, Nobuki Kazuta, Kazuma Nakashima

Pageof 3

Frequent Collaborators

16 joint publications

Hiroyuki Watanabe

16 joint publications

Masahiro Ono

4 joint publications

Kosuke Saito

1 joint publications

Takuma Hasegawa